NasdaqGM - Delayed Quote USD

Tema Obesity & Cardiometabolic ETF (HRTS)

34.34 +0.35 (+1.03%)
At close: 4:00 PM EDT
Loading Chart for HRTS
DELL
  • Previous Close 33.99
  • Open 33.96
  • Bid 31.62 x 100
  • Ask 36.73 x 100
  • Day's Range 33.96 - 34.44
  • 52 Week Range 26.26 - 36.03
  • Volume 35,285
  • Avg. Volume 20,818
  • Net Assets 82.55M
  • NAV 33.98
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return 11.04%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.75%

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

Tema Global Limited

Fund Family

Health

Fund Category

82.55M

Net Assets

2023-11-20

Inception Date

Performance Overview: HRTS

View More

Trailing returns as of 10/15/2024. Category is Health.

YTD Return

HRTS
11.04%
Category
10.57%
 

1-Year Return

HRTS
0.00%
Category
21.36%
 

3-Year Return

HRTS
0.00%
Category
0.43%
 

People Also Watch

Holdings: HRTS

View More

Top 10 Holdings (43.92% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 8.04%
ALNY
Alnylam Pharmaceuticals, Inc. 5.43%
LLY
Eli Lilly and Company 5.36%
VRTX
Vertex Pharmaceuticals Incorporated 4.38%
NOVO-B.CO
Novo Nordisk A/S 3.94%
4519.T
Chugai Pharmaceutical Co., Ltd. 3.75%
BBIO
BridgeBio Pharma, Inc. 3.46%
AZN.L
AstraZeneca PLC 3.27%
CYTK
Cytokinetics, Incorporated 3.23%
CRNX
Crinetics Pharmaceuticals, Inc. 3.07%

Sector Weightings

SectorHRTS
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: HRTS

View More

Research Reports: HRTS

View More
  • Daily – Vickers Top Buyers & Sellers for 10/09/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 10/01/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Lowering target price to $63.00

    GXO LOGISTICS INC has an Investment Rating of BUY; a target price of $63.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins, Leading to Valuation Increase

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

    Rating
    Price Target
     

Related Tickers